The Journal of Pain
Volume 11, Issue 2 , Pages 109-118, February 2010

The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders

  • John T. Farrar

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationAddress reprint requests to Dr John T. Farrar, University of Pennsylvania School of Medicine, 423 Guardian Drive, Room 816, Philadelphia, PA 19041.
  • ,
  • Yili L. Pritchett

      Affiliations

    • Global Pharmaceutical R&D, Abbott Laboratories, Abbot Park, Illinois
  • ,
  • Michael Robinson

      Affiliations

    • Lilly USA, LLC, Indianapolis, Indiana
  • ,
  • Apurva Prakash

      Affiliations

    • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana
  • ,
  • Amy Chappell

      Affiliations

    • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

Received 8 December 2008; received in revised form 12 May 2009; accepted 8 June 2009. published online 10 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work utilized data from clinical trials sponsored by Eli Lilly and Company, Indianapolis, Indiana.

PII: S1526-5900(09)00588-4

doi:10.1016/j.jpain.2009.06.007

The Journal of Pain
Volume 11, Issue 2 , Pages 109-118, February 2010